Tickets and Sponsorships Still Available for the 2023 Prevent Blindness Person of Vision Award Gala Honoring Megan Molony, National Vision, Inc.

By Staff
Tuesday, January 24, 2023 12:24 AM CHICAGO—Tickets and sponsorships are still available for the 2023 Prevent Blindness Person of Vision Award event, honoring Megan Molony, senior vice president, chief merchandising and managed care officer, of National Vision Inc. The award presentation event will take place on March 16, 2023, at 583 Park Avenue, New York, N.Y., in conjunction with Vision Expo East. As VMAIL reported, the Prevent Blindness Person of Vision Award recognizes an individual, corporation and/or organization whose inspired outlook champions healthy vision and its importance for a healthy life. Individual tickets may be purchased for $350 per person directly at

U.S. Blindness Rates Are Expected to Double by 2050, CDC Says

By Staff
Friday, January 13, 2023 12:36 PM The number of Americans with blindness is expected to rise over the next 30 years. The Centre for Disease Control (CDC) recently released new figures highlighting the burden of vision loss in the U.S. The number of people with blindness is expected to double from 1.02 million in 2015 to 2.1 million by 2050. 

Chronic disease will also be a factor in rising vision problems among U.S. adults. Rates of glaucoma are expected to top more than 5.5 million, and the number of people with macular degeneration is projected to reach more than 4.4 million.

The economic cost of vision loss is expected to reach $373 billion by 2050. The CDC is calling on health professionals to work with patients to ensure they are getting their vision tested, noting that early detection and timely treatment of conditions like diabetic retinopathy can significantly prevent vision loss. CDC stats show that 90 percent of blindness caused by diabetes is preventable with proper eyecare.

What’s on the Horizon for Glaucoma Treatment and Detection?

By Mary Kane
Friday, January 13, 2023 8:30 AM According to the Centers for Disease Control and Prevention, about three million Americans have glaucoma and the disease is the second leading cause of blindness worldwide. January is officially National Glaucoma Awareness month and during this time, it’s important to spread the word about this group of diseases that affects many Americans every year. VMAIL Weekend recently sat down with Ashish Singh, MD, who specializes in cataract and refractive surgery at Kleiman Evangelista Eye Centers. Here’s what he had to say about the early signs of glaucoma, encouraging high-risk patients to get screened on a regular basis and new glaucoma treatments.

Registration Is Open for Eyes On Dry Eye 2023

By Staff
Monday, January 9, 2023 12:15 AM SAN DIEGO—The optical industry’s largest dry eye event is open for registration. Scheduled for February 24 and 25, Eyes On Dry Eye is a two-day virtual educational summit that provides eyecare professionals with the latest research and education on dry eye in live sessions and interactive Q&A with industry experts. Dry eye disease affects more than 49 million Americans.

Prevent Blindness Kicks Off National Glaucoma Awareness Month by Inviting Patients and Caregivers to Join Glaucoma Community

By Staff
Tuesday, January 3, 2023 12:21 AM CHICAGO—As part of January’s National Glaucoma Awareness Month, Prevent Blindness is offering a wide variety of free resources to help glaucoma patients and their caregivers find the support they need to address the many aspects of the eye disease.

Visioneering Reports 100 Percent Enrollment in Myopia Progression Control Study

By Staff
Friday, December 30, 2022 12:24 AM ATLANTA, Ga.—U.S.-based medical device company and producer of the NaturalVue Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc. recently announced it has enrolled 100 percent of the subjects in its international randomized controlled clinical trial known as ‘PROTECT’ (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial). The study objective is to demonstrate and quantify the effectiveness of its NaturalVue Multifocal Contact Lenses in myopia progression control in children, Visioneering said. PROTECT is a multi-center, randomized, double-masked clinical trial with participating investigators in centers in Canada, the United States, Hong Kong, and Singapore.

Eye Protection Via Rx Safety Programs Allows ECPs to Make a Difference

By Staff
Friday, December 30, 2022 12:18 AM Thousands of eye injuries happen every day, spanning accidents at home, in amateur or professional sports or in the workplace. In fact, Prevent Blindness estimates that eye injuries in the workplace are very common.

Kellogg Empowers Blind Consumers in U.S. With NaviLens Technology on Packaging

By Staff
Wednesday, December 28, 2022 12:21 AM BATTLE CREEK, Mich.—Kellogg Company is changing the way the almost 12 million adults in the U.S. who are blind or have low vision perform daily tasks, such as navigating a grocery store aisle or choosing one's cereal at breakfast.

InfantSEE Celebrates 165,000 Assessments Since 2005

By Staff
Wednesday, December 28, 2022 12:18 AM ST. LOUIS—Concluding another groundbreaking year, InfantSEE, a program that provides no-cost, comprehensive eye and vision health assessments for infants, celebrated 165,000 assessments since the initiative’s inception in 2005.

Xenon-VR Announces Name Change to Xenon Ophthalmics and Patents Are Granted

By Staff
Thursday, December 22, 2022 12:21 AM BELLEVILLE, N.J.—Xenon-VR, Inc., based here, announced that it has changed its name to Xenon Ophthalmics Inc. "The new name reflects our industry emphasis and expertise," said Zeshan Khan, president, founder and CEO.

STAAR Surgical’s Caren Mason to Retire, Thomas Frinzi Is Named New President

By Staff
Wednesday, December 21, 2022 12:27 AM LAKE FOREST, Calif.—STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses for the eye, announced that president and CEO Caren Mason will be retiring on Dec. 31, 2022, after leading the company through a significant period of revitalization and growth for more than seven years.

Researchers Find Symptoms of Stress-Induced Retinal Aging and Natural Aging Are Similar

By Staff
Monday, December 5, 2022 12:15 AM IRVINE, Calif.—New research from the University of California, Irvine, suggests aging is an important component of retinal ganglion cell death in glaucoma, and that novel pathways can be targeted when designing new treatments for glaucoma patients.

Sightpath Medical Acquires Accusite Surgical

By Staff
Tuesday, November 29, 2022 12:18 AM BLOOMINGTON, Minn.—Sightpath Medical, a leading provider of mobile ophthalmic services for cataract and refractive surgery, announced that it has acquired Accusite Surgical, a cataract surgery equipment outsourcing company.